Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy
Highlights • SUVMax is a poor predictive parameter when compared with volumetric parameters (MTV, TLG). • MTV and/or TLG pre-treatment are well correlated with clinical outcome. • MTV had a better predictive value than GTV and/or AJCC staging.
Gespeichert in:
| Veröffentlicht in: | Critical reviews in oncology/hematology 2016-12, Vol.108, p.40-51 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 51 |
|---|---|
| container_issue | |
| container_start_page | 40 |
| container_title | Critical reviews in oncology/hematology |
| container_volume | 108 |
| creator | Castelli, J Bari, B. De Depeursinge, A Simon, A Devillers, A Jimenez, G. Roman Prior, J Ozsahin, M Crevoisier, R.de Bourhis, J |
| description | Highlights • SUVMax is a poor predictive parameter when compared with volumetric parameters (MTV, TLG). • MTV and/or TLG pre-treatment are well correlated with clinical outcome. • MTV had a better predictive value than GTV and/or AJCC staging. |
| doi_str_mv | 10.1016/j.critrevonc.2016.10.009 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_01479228v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1040842816302736</els_id><sourcerecordid>1847891741</sourcerecordid><originalsourceid>FETCH-LOGICAL-c513t-e5449a980a6b1a6e13f832c28f1669439fb12185067e3f2fecdfeba03e8fb0133</originalsourceid><addsrcrecordid>eNqNkk9v1DAQxSMEoqXwFZCPcMjisb2OfUEqpX-QVioS5Ww5zkTxNptsbSfVfnscthSJEydbz2_eWPOboiBAV0BBftquXPAp4DwObsWykuUVpfpFcQqq0iUVEl7mOxW0VIKpk-JNjFtKqRCyel2csEpzUFyfFuF2xjB7fCRjS1KHZB-w8S75Gcls-wkX_WGyQ_LJ_lZBkauv1-T75R3xA-nQNsQODRnQ3RNnB4eB5J_ZhA159KkjrsPdGGzjxxwf7P7wtnjV2j7iu6fzrPh5dXl3cVNubq-_XZxvSrcGnkpcC6GtVtTKGqxE4K3izDHVgpRacN3WwECtqayQt6xF17RYW8pRtTUFzs-Kj8fczvZmH_zOhoMZrTc35xuzaBREpRlTM2Tvh6N3H8aHCWMyOx8d9r0dcJyiASUqpaESi1UdrS6MMQZsn7OBmoWO2Zq_dMxCZ3nJdHLp-6cuU73D5rnwD45s-HI0YJ5LphJMdB7zTBsf0CXTjP5_unz-J8T1fvDO9vd4wLgdpzDkuRswkRlqfixbsiwJSE5ZxSX_BX11ulo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1847891741</pqid></control><display><type>article</type><title>Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Castelli, J ; Bari, B. De ; Depeursinge, A ; Simon, A ; Devillers, A ; Jimenez, G. Roman ; Prior, J ; Ozsahin, M ; Crevoisier, R.de ; Bourhis, J</creator><creatorcontrib>Castelli, J ; Bari, B. De ; Depeursinge, A ; Simon, A ; Devillers, A ; Jimenez, G. Roman ; Prior, J ; Ozsahin, M ; Crevoisier, R.de ; Bourhis, J</creatorcontrib><description>Highlights • SUVMax is a poor predictive parameter when compared with volumetric parameters (MTV, TLG). • MTV and/or TLG pre-treatment are well correlated with clinical outcome. • MTV had a better predictive value than GTV and/or AJCC staging.</description><identifier>ISSN: 1040-8428</identifier><identifier>EISSN: 1879-0461</identifier><identifier>DOI: 10.1016/j.critrevonc.2016.10.009</identifier><identifier>PMID: 27931839</identifier><language>eng</language><publisher>Netherlands: Elsevier Ireland Ltd</publisher><subject>Bioengineering ; Cancer ; Chemoradiotherapy ; Clinical outcome ; Fluorodeoxyglucose F18 ; Glycolysis ; Head and neck cancer ; Head and Neck Neoplasms - diagnostic imaging ; Head and Neck Neoplasms - therapy ; Hematology, Oncology and Palliative Medicine ; Humans ; Imaging ; Life Sciences ; PET ; Positron Emission Tomography Computed Tomography</subject><ispartof>Critical reviews in oncology/hematology, 2016-12, Vol.108, p.40-51</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2016 Elsevier Ireland Ltd</rights><rights>Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c513t-e5449a980a6b1a6e13f832c28f1669439fb12185067e3f2fecdfeba03e8fb0133</citedby><cites>FETCH-LOGICAL-c513t-e5449a980a6b1a6e13f832c28f1669439fb12185067e3f2fecdfeba03e8fb0133</cites><orcidid>0000-0003-4641-6186</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1040842816302736$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27931839$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://univ-rennes.hal.science/hal-01479228$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Castelli, J</creatorcontrib><creatorcontrib>Bari, B. De</creatorcontrib><creatorcontrib>Depeursinge, A</creatorcontrib><creatorcontrib>Simon, A</creatorcontrib><creatorcontrib>Devillers, A</creatorcontrib><creatorcontrib>Jimenez, G. Roman</creatorcontrib><creatorcontrib>Prior, J</creatorcontrib><creatorcontrib>Ozsahin, M</creatorcontrib><creatorcontrib>Crevoisier, R.de</creatorcontrib><creatorcontrib>Bourhis, J</creatorcontrib><title>Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy</title><title>Critical reviews in oncology/hematology</title><addtitle>Crit Rev Oncol Hematol</addtitle><description>Highlights • SUVMax is a poor predictive parameter when compared with volumetric parameters (MTV, TLG). • MTV and/or TLG pre-treatment are well correlated with clinical outcome. • MTV had a better predictive value than GTV and/or AJCC staging.</description><subject>Bioengineering</subject><subject>Cancer</subject><subject>Chemoradiotherapy</subject><subject>Clinical outcome</subject><subject>Fluorodeoxyglucose F18</subject><subject>Glycolysis</subject><subject>Head and neck cancer</subject><subject>Head and Neck Neoplasms - diagnostic imaging</subject><subject>Head and Neck Neoplasms - therapy</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Imaging</subject><subject>Life Sciences</subject><subject>PET</subject><subject>Positron Emission Tomography Computed Tomography</subject><issn>1040-8428</issn><issn>1879-0461</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk9v1DAQxSMEoqXwFZCPcMjisb2OfUEqpX-QVioS5Ww5zkTxNptsbSfVfnscthSJEydbz2_eWPOboiBAV0BBftquXPAp4DwObsWykuUVpfpFcQqq0iUVEl7mOxW0VIKpk-JNjFtKqRCyel2csEpzUFyfFuF2xjB7fCRjS1KHZB-w8S75Gcls-wkX_WGyQ_LJ_lZBkauv1-T75R3xA-nQNsQODRnQ3RNnB4eB5J_ZhA159KkjrsPdGGzjxxwf7P7wtnjV2j7iu6fzrPh5dXl3cVNubq-_XZxvSrcGnkpcC6GtVtTKGqxE4K3izDHVgpRacN3WwECtqayQt6xF17RYW8pRtTUFzs-Kj8fczvZmH_zOhoMZrTc35xuzaBREpRlTM2Tvh6N3H8aHCWMyOx8d9r0dcJyiASUqpaESi1UdrS6MMQZsn7OBmoWO2Zq_dMxCZ3nJdHLp-6cuU73D5rnwD45s-HI0YJ5LphJMdB7zTBsf0CXTjP5_unz-J8T1fvDO9vd4wLgdpzDkuRswkRlqfixbsiwJSE5ZxSX_BX11ulo</recordid><startdate>20161201</startdate><enddate>20161201</enddate><creator>Castelli, J</creator><creator>Bari, B. De</creator><creator>Depeursinge, A</creator><creator>Simon, A</creator><creator>Devillers, A</creator><creator>Jimenez, G. Roman</creator><creator>Prior, J</creator><creator>Ozsahin, M</creator><creator>Crevoisier, R.de</creator><creator>Bourhis, J</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0003-4641-6186</orcidid></search><sort><creationdate>20161201</creationdate><title>Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy</title><author>Castelli, J ; Bari, B. De ; Depeursinge, A ; Simon, A ; Devillers, A ; Jimenez, G. Roman ; Prior, J ; Ozsahin, M ; Crevoisier, R.de ; Bourhis, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c513t-e5449a980a6b1a6e13f832c28f1669439fb12185067e3f2fecdfeba03e8fb0133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Bioengineering</topic><topic>Cancer</topic><topic>Chemoradiotherapy</topic><topic>Clinical outcome</topic><topic>Fluorodeoxyglucose F18</topic><topic>Glycolysis</topic><topic>Head and neck cancer</topic><topic>Head and Neck Neoplasms - diagnostic imaging</topic><topic>Head and Neck Neoplasms - therapy</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Imaging</topic><topic>Life Sciences</topic><topic>PET</topic><topic>Positron Emission Tomography Computed Tomography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Castelli, J</creatorcontrib><creatorcontrib>Bari, B. De</creatorcontrib><creatorcontrib>Depeursinge, A</creatorcontrib><creatorcontrib>Simon, A</creatorcontrib><creatorcontrib>Devillers, A</creatorcontrib><creatorcontrib>Jimenez, G. Roman</creatorcontrib><creatorcontrib>Prior, J</creatorcontrib><creatorcontrib>Ozsahin, M</creatorcontrib><creatorcontrib>Crevoisier, R.de</creatorcontrib><creatorcontrib>Bourhis, J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Critical reviews in oncology/hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Castelli, J</au><au>Bari, B. De</au><au>Depeursinge, A</au><au>Simon, A</au><au>Devillers, A</au><au>Jimenez, G. Roman</au><au>Prior, J</au><au>Ozsahin, M</au><au>Crevoisier, R.de</au><au>Bourhis, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy</atitle><jtitle>Critical reviews in oncology/hematology</jtitle><addtitle>Crit Rev Oncol Hematol</addtitle><date>2016-12-01</date><risdate>2016</risdate><volume>108</volume><spage>40</spage><epage>51</epage><pages>40-51</pages><issn>1040-8428</issn><eissn>1879-0461</eissn><abstract>Highlights • SUVMax is a poor predictive parameter when compared with volumetric parameters (MTV, TLG). • MTV and/or TLG pre-treatment are well correlated with clinical outcome. • MTV had a better predictive value than GTV and/or AJCC staging.</abstract><cop>Netherlands</cop><pub>Elsevier Ireland Ltd</pub><pmid>27931839</pmid><doi>10.1016/j.critrevonc.2016.10.009</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0003-4641-6186</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1040-8428 |
| ispartof | Critical reviews in oncology/hematology, 2016-12, Vol.108, p.40-51 |
| issn | 1040-8428 1879-0461 |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_01479228v1 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Bioengineering Cancer Chemoradiotherapy Clinical outcome Fluorodeoxyglucose F18 Glycolysis Head and neck cancer Head and Neck Neoplasms - diagnostic imaging Head and Neck Neoplasms - therapy Hematology, Oncology and Palliative Medicine Humans Imaging Life Sciences PET Positron Emission Tomography Computed Tomography |
| title | Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T13%3A38%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Overview%20of%20the%20predictive%20value%20of%20quantitative%2018%20FDG%20PET%20in%20head%20and%20neck%20cancer%20treated%20with%20chemoradiotherapy&rft.jtitle=Critical%20reviews%20in%20oncology/hematology&rft.au=Castelli,%20J&rft.date=2016-12-01&rft.volume=108&rft.spage=40&rft.epage=51&rft.pages=40-51&rft.issn=1040-8428&rft.eissn=1879-0461&rft_id=info:doi/10.1016/j.critrevonc.2016.10.009&rft_dat=%3Cproquest_hal_p%3E1847891741%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1847891741&rft_id=info:pmid/27931839&rft_els_id=S1040842816302736&rfr_iscdi=true |